Amanote Research
Register
Sign In
Are Currently Available Biomarkers Useful to Discriminate CSU Patients Not Controlled by Low Dose Omalizumab Maintenance Therapy?
European Annals of Allergy and Clinical Immunology
- Italy
doi 10.23822/eurannaci.1764-1489.139
Full Text
Open PDF
Abstract
Available in
full text
Categories
Allergy
Immunology
Date
March 1, 2020
Authors
R. Asero
Publisher
Edra SpA
Related search
Omalizumab in Patients With Antihistamine-Resistant CSU
British Journal of Dermatology
Dermatology
Medicine
Antinuclear Antibodies Are Common and Linked to Poor Response to Omalizumab Treatment in Patients With CSU
Allergy: European Journal of Allergy and Clinical Immunology
Allergy
Immunology
Clinical Effectiveness of Currently Available Low-Vision Devices in Glaucoma Patients With Moderate-To-Severe Vision Loss
Clinical Ophthalmology
Ophthalmology
Effects of Omalizumab on Chronic Urticaria Not Responding to Recommended Therapy
Allergy, Asthma and Clinical Immunology
Immunology
Pulmonary
Allergy
Respiratory Medicine
Is Echocardiographic Assessment of Dyssynchrony Useful to Select Candidates for Cardiac Resynchronization Therapy?: Echocardiography Is Not Useful Before Cardiac Resynchronization Therapy if QRS Duration Is Available
Circulation. Cardiovascular imaging
Nuclear Medicine
Radiology
Cardiology
Cardiovascular Medicine
Imaging
Medicine
How to Meet Legitimate Expectations of Patients When Authorized Medicinal Products Are Not Available
Pharmaceutical Regulatory Affairs: Open Access
Low Dose Maintenance Medication for Schizophrenia
BMJ
Indacaterol Therapy in Patients With COPD Not Receiving Other Maintenance Treatment
Respiratory Medicine
Pulmonary
Respiratory Medicine
Maintenance of Remission With Low-Dose Olopatadine Hydrochloride for Itch in Well-Controlled Chronic Urticaria
Clinical, Cosmetic and Investigational Dermatology
Dermatology
